CollPlant Biotechnologies Ltd. (CLGN), a regenerative and aesthetic medicine company, Monday announced the expansion of distribution of its Vergenix STR product in Europe and Asia.
The product is based on its rhCollagen technology and helps treat tendon injuries, including tennis elbow, rotator cuff, patellar, Achilles, and hand tendons.
The new distributor for Benelux and Spain specializes in medical device sales, particularly in orthopedics, and received its first shipment from CollPlant in February.
In Turkey and India, the distributors, which also focus on medical devices, are completing regulatory approvals and plan to start selling VergenixSTR in 2025.
Recently, CollPlant signed agreements with distributors in the Netherlands, Turkey, and India to sell VergenixSTR.
VergenixSTR is a soft tissue repair material that blends cross-linked rhCollagen with platelet-rich plasma, a blood component rich in platelets, which play a key role in healing.
For comments and feedback contact: editorial@rttnews.com
Business News
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.